STEMGENT, INC.

Profile

Company Names

STEMGENT, INC.
STEMGENT INC

Addresses

ONE KENDALL SQUARE, SUITE B6201, CAMBRIDGE, MA 02139

ONE KENDAL SQUARE, CAMBRIDGE, MA 02139

Phone Numbers

617.494.0398
617-245-0000

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$32,260,392.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2012-06-04 
$11,299,993.00 
$11,299,993.00 
$0.00 
Equity 
5
2012-01-06 
$6,297,998.00 
$8,797,992.00 
$2,499,994.00 
Equity 
4
2011-10-13 
$584,810.00 
$600,000.00 
$15,190.00 
Debt 
3
2011-03-29 
$750,000.00 
$3,000,000.00 
$2,250,000.00 
Debt 
2
2010-04-30 
$10,627,591.00 
$14,127,591.00 
$3,500,000.00 
Equity 
1
2009-11-12 
$2,700,000.00 
$3,000,000.00 
$300,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RALPH 
 
CHRISTOFFERSEN 
DIRECTOR
GLOBEIMMUNE INC   |  STEMGENT, INC.   |  CALITHERA BIOSCIENCES, INC.   |  GALLEON PHARMACEUTICALS INC   |  CATALYST BIOSCIENCES INC   |  SCIODERM, LLC   |  SCIODERM, INC.
RALPH 
E. 
CHRISTOFFERSEN 
DIRECTOR
STEMGENT INC   |  ELCELYX THERAPEUTICS, INC.   |  STEMGENT, INC.   |  TRAGARA PHARMACEUTICALS, INC.   |  LIGHTSTONE VENTURES, L.P.   |  LIGHTSTONE VENTURES (A), L.P.   |  LIGHTSTONE VENTURES (AIV), L.P.   |  LIGHTSTONE VENTURES (A) (AIV), L.P.   |  CALITHERA BIOSCIENCES, INC.
AUGUSTINE 
 
LAWLOR 
DIRECTOR
GLOBEIMMUNE INC   |  VAXINNATE CORP   |  STEMGENT INC   |  US GENOMICS INC   |  STEMGENT, INC.   |  PATHOGENETIX, INC.   |  CARDIOVASCULAR SYSTEMS INC   |  SHAPE PHARMACEUTICALS, INC.   |  ANEXON, INC.   |  DEKKUN CORP   |  NANOMR, INC.   |  MOSAIC BIOSCIENCES, INC.   |  APOFORE CORP   |  TENSHA THERAPEUTICS, INC.   |  GITR INC.   |  CATALYST BIOSCIENCES INC   |  LEAP THERAPEUTICS, INC.   |  PAINREFORM LTD.   |  LAYERBIO, INC.
STEFAN 
 
MILTENYI 
DIRECTOR
STEMGENT, INC.
IAN 
 
RATCLIFFE 
DIRECTOR, EXECUTIVE OFFICER, PROMOTER
GLOBAL CELL SOLUTIONS INC   |  STEMGENT INC   |  STEMGENT, INC.   |  ENZYMATICS INC   |  FRESHAIR SENSOR LLC   |  MITRA RXDX, INC.   |  AGILIS BIOTHERAPEUTICS, INC.   |  AVITIDE, INC.   |  ACESSA HEALTH INC.   |  SANDS CAPITAL PRIVATE GROWTH FUND III, L.P.   |  NANOVIEW DIAGNOSTICS INC.   |  SANDS CAPITAL VENTURES FUND-SLK, L.P.   |  TECKRO, INC.   |  SANDS CAPITAL PRIVATE GROWTH FUND III-DC, L.P.   |  SCM-S72-1, LLC   |  NANOVIEW BIOSCIENCES, INC.   |  VITARA BIOMEDICAL, INC.   |  SANDS CAPITAL GLOBAL VENTURE FUND III, L.P.
HAROLD 
 
WERNER 
DIRECTOR
TETRALOGIC PHARMACEUTICALS CORP   |  STEMGENT, INC.   |  INFACARE PHARMACEUTICAL CORP
HAROLD 
R. 
WERNER 
DIRECTOR
XENCOR INC   |  STEMGENT INC   |  PROMEDIOR INC   |  STEMGENT, INC.   |  DECIMMUNE THERAPEUTICS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-08-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-04 
2012-01-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-01-06 
2011-10-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-10-13 
2011-06-10
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-30 
2011-04-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-03-29 
2010-05-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-30 
2009-11-24
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2009-11-12 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#